Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 38621 - 38640 out of 558245 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Australia | (L01FF03) durvalumab (adm: P) | Imfinzi 500 mg/10 mL injection, 10 mL vial | Solution concentrate for I.V. infusion 500 mg in 10 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | AstraZenecaPtyLtd |
| Australia | (L01FF03) durvalumab (adm: P) | Imfinzi 500 mg/10 mL injection, 10 mL vial | Solution concentrate for I.V. infusion 500 mg in 10 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | AstraZenecaPtyLtd |
| Australia | (L01FF03) durvalumab (adm: P) | Imfinzi 500 mg/10 mL injection, 10 mL vial | Solution concentrate for I.V. infusion 500 mg in 10 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | AstraZenecaPtyLtd |
| Australia | (L01FF03) durvalumab (adm: P) | Imfinzi 500 mg/10 mL injection, 10 mL vial | Solution concentrate for I.V. infusion 500 mg in 10 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | AstraZenecaPtyLtd |
| Australia | (L01FF03) durvalumab (adm: P) | Imfinzi 500 mg/10 mL injection, 10 mL vial | Solution concentrate for I.V. infusion 500 mg in 10 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | AstraZenecaPtyLtd |
| Australia | (L01FF03) durvalumab (adm: P) | Imfinzi 500 mg/10 mL injection, 10 mL vial | Solution concentrate for I.V. infusion 500 mg in 10 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | AstraZenecaPtyLtd |
| Australia | (L01FF03) durvalumab (adm: P) | Imfinzi 500 mg/10 mL injection, 10 mL vial | Solution concentrate for I.V. infusion 500 mg in 10 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | AstraZenecaPtyLtd |
| Australia | (L01FF03) durvalumab (adm: P) | Imfinzi 500 mg/10 mL injection, 10 mL vial | Solution concentrate for I.V. infusion 500 mg in 10 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | AstraZenecaPtyLtd |
| Australia | (L01FF03) durvalumab (adm: P) | Imfinzi 500 mg/10 mL injection, 10 mL vial | Solution concentrate for I.V. infusion 500 mg in 10 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | AstraZenecaPtyLtd |
| Australia | (L01FF03) durvalumab (adm: P) | Imfinzi 500 mg/10 mL injection, 10 mL vial | Solution concentrate for I.V. infusion 500 mg in 10 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | AstraZenecaPtyLtd |
| Australia | (L01FF03) durvalumab (adm: P) | Imfinzi 500 mg/10 mL injection, 10 mL vial | Solution concentrate for I.V. infusion 500 mg in 10 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | AstraZenecaPtyLtd |
| Australia | (L01FF03) durvalumab (adm: P) | Imfinzi 500 mg/10 mL injection, 10 mL vial | Solution concentrate for I.V. infusion 500 mg in 10 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | AstraZenecaPtyLtd |
| Australia | (L01FF04) avelumab (adm: P) | Bavencio 200 mg/10 mL injection, 10 mL vial | Solution concentrate for I.V. infusion 200 mg in 10 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Neuroendocrine Tumors | MerckHealthcarePtyLtd |
| Australia | (L01FF04) avelumab (adm: P) | Bavencio 200 mg/10 mL injection, 10 mL vial | Solution concentrate for I.V. infusion 200 mg in 10 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Neuroendocrine Tumors | MerckHealthcarePtyLtd |
| Australia | (L01FF04) avelumab (adm: P) | Bavencio 200 mg/10 mL injection, 10 mL vial | Solution concentrate for I.V. infusion 200 mg in 10 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Neuroendocrine Tumors | MerckHealthcarePtyLtd |
| Australia | (L01FF04) avelumab (adm: P) | Bavencio 200 mg/10 mL injection, 10 mL vial | Solution concentrate for I.V. infusion 200 mg in 10 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Neuroendocrine Tumors | MerckHealthcarePtyLtd |
| Australia | (L01FF04) avelumab (adm: P) | Bavencio 200 mg/10 mL injection, 10 mL vial | Solution concentrate for I.V. infusion 200 mg in 10 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Neuroendocrine Tumors | MerckHealthcarePtyLtd |
| Australia | (L01FF04) avelumab (adm: P) | Bavencio 200 mg/10 mL injection, 10 mL vial | Solution concentrate for I.V. infusion 200 mg in 10 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Neuroendocrine Tumors | MerckHealthcarePtyLtd |
| Australia | (L01FF04) avelumab (adm: P) | Bavencio 200 mg/10 mL injection, 10 mL vial | Solution concentrate for I.V. infusion 200 mg in 10 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Neuroendocrine Tumors | MerckHealthcarePtyLtd |
| Australia | (L01FF04) avelumab (adm: P) | Bavencio 200 mg/10 mL injection, 10 mL vial | Solution concentrate for I.V. infusion 200 mg in 10 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Neuroendocrine Tumors | MerckHealthcarePtyLtd |
Pages
